Tag Archives: Bristol-Myers Squibb
Anorexia and Cachexia – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment
Anorexia in Cancer Cancer anorexia-cachexia syndrome (CACS) is an extremely common condition in cancer patients. It is estimated that 50% of cancer patients suffered from anorexia. The exact frequency of CACS varies according to the primary pathology (from 30% in … Continue reading →
Posted in Cancer, Gastric Cancer, Others, Pancreatic Cancer
|
Tagged AIDS, Anorexia, Bristol-Myers Squibb, Cachexia, Causes, chemotherapy, cyprohetadine, Diagnosis, dronabinol, Gastric Cancer, Lymphoma, malnutrition, Marinol, Megace, megestrol, Merck, Metastatic breast cancer, orexigenic, Oxandrin, oxandrolone, Pancreatic Cancer, Periactin, Prognosis, Symptoms, Treatment, Unimed, wasting
|
2 Comments
FDA Approves Halaven for Late-Stage Breast Cancer
Good news for patients with late stage metastatic breast cancer. The US Food and Drug Administration (FDA) approved eribulin mesylate injection (Halaven; Eisai, Inc) for the treatment of metastatic breast cancer in patients who have received at least 2 prior … Continue reading →
Posted in Breast cancer, Cancer
|
Tagged anthracycline, Bristol-Myers Squibb, capecitabine, chemotherapy, Eisai, eribulin, Halaven, ixabepilone, Ixempra, Metastatic breast cancer, paclitaxel, resistant, Roche, Survival, taxane, Xeloda
|
Comments Off on FDA Approves Halaven for Late-Stage Breast Cancer